COMMUNIQUÉS West-GlobeNewswire
-
National NUCCA doctors highlight importance of spinal health for daily function, better quality of life during World Spine Day observance
27/10/2026 -
AscellaHealth Executive Manager Wins 2026 Herizon Award, Recognizing Established Leadership in Team and Department Transformation
27/10/2026 -
AdipoPharma Advances PATAS into Phase 1b Clinical Trial in Patients with Type 2 Diabetes
27/10/2026 -
1104Health and Johns Hopkins Researchers Present Data on Physician Collaboration Across Community and Academic Oncology
27/10/2026 -
Les Canadiens souhaitent assister à des événements sportifs féminins professionnels. La plupart des amateurs ignorent cependant où les trouver.
27/10/2026 -
Canadians Want Professional Women’s Sport. Most Fans Don’t Know Where to Find it.
27/10/2026 -
Four Years After St. Paul Acquisition, Pro-Tech Design & Manufacturing Shows Medtech Consolidation Doesn't Have to Mean Disruption
27/10/2026 -
Bavarian Nordic to Supply and Donate Vaccines for Global Mpox Emergency Stockpile
27/10/2026 -
Addition Therapeutics to Present Preclinical Data from PRINT™ Programs at the European Society of Gene & Cell Therapy’s (ESGCT) 33rd Annual Congress
27/10/2026 -
UK health tech pioneer Patients Know Best launches global expansion at HLTH Las Vegas
27/10/2026 -
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2026
27/10/2026 -
CDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch
27/10/2026 -
Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors
27/10/2026 -
vTv Therapeutics Announces First Participant Randomized in Phase 2a Pilot Study Evaluating Cadisegliatin in Individuals with Type 1 Diabetes (T1D) Using Hybrid Closed-Loop (HCL) Insulin Delivery Systems
27/10/2026 -
Stryker to participate in the 2026 Jefferies Global Healthcare Conference
27/10/2026 -
Enlivex Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal
27/10/2026 -
Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026
27/10/2026 -
Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution
27/10/2026 -
AssistRx Named a Central Florida Top Workplace for Sixth Consecutive Year
27/10/2026
Pages